Daily chronic headache.
Saper
J R
JR
Michigan Head-Pain and Neurological Institute, Michigan State University, Ann Arbor.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002908:Chronic Disease; D002985:Clinical Protocols / Q000592:standards; D004874:Ergonovine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006261:Headache / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D006757:Hospital Units / Q000458:organization & administration; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000928:Antidepressive Agents; D001569:Benzodiazepines; D004874:Ergonovine; D008784:Methysergide